Rubicon Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$565K Hold
489
– – 0.39% 55
2026
Q2
$586K Sell
489
-10
-2% -$10.2K 0.43% 51
2026
Q1
$459K Hold
499
– – 0.4% 46
2025
Q4
$536K Buy
+499
New +$477K 0.5% 35

Other funds holding LLY

Rubicon Advisors's LLY Position: Q3 2026 in Review

Rubicon Advisors held its Eli Lilly (LLY) position steady in Q3 2026 at 489 shares worth $565K. The position accounts for 0.39% of the portfolio, ranked #55.

Rubicon Advisors first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $586K in Q2 2026. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Rubicon Advisors held 489 shares of Eli Lilly worth $565K as of Q3 2026.
  • Rubicon Advisors left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.39% of Rubicon Advisors's portfolio in Q3 2026, its #55 holding.
  • Rubicon Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Rubicon Advisors's Eli Lilly position peaked at $586K in Q2 2026.
  • 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Rubicon Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.